Out-of-Pocket Costs for Long-Acting Reversible Contraception Among Individuals Enrolled in Employer Sponsored Insurance Plans
-
By
-
Mikhaila Richards
-
June 16, 2026
-
Clinical Scorecard: Out-of-Pocket Expenses for Long-Acting Reversible Contraceptives in Individuals with Employer-Sponsored Insurance
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Intrauterine devices (IUD) and contraceptive implants |
| Target Population | Women aged 15-49 with employer-sponsored insurance |
| Care Setting | Outpatient healthcare settings |
Key Highlights
- ACA mandates contraceptives without cost-sharing
- Privately insured users of LARC face out-of-pocket costs
- Study analyzed 98,916 IUD and 30,259 implant insertion encounters
- Research conducted using 2023 Merative MarketScan database
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Privately insured women aged 15-49
Out-of-pocket expenses for LARC insertion
Clinical Best Practices
Related Resources & Content
